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Abstract
The renal distal tubules and collecting ducts play a key role in the control of electrolyte 
and fluid homeostasis. The discovery of highly calcium selective channels, Transient 
Receptor Potential Vanilloid 5 (TRPV5) of the TRP superfamily, has clarified the nature 
of the calcium entry channels.  It has been proposed that this channel mediates the critical 
Ca2+ entry step in transcellular Ca2+ re-absorption in the kidney. The regulation of 
transmembrane Ca2+ flux through TRPV5 is of particular importance for whole body 
calcium homeostasis.
In this study, we provide evidence that the TRPV5 channel is present in rat cortical 
collecting duct (RCCD2) cells at mRNA and protein levels. We demonstrate that 
17estradiol (E2) is involved in the regulation of Ca2+ influx in these cells via the 
epithelial Ca2+ channels TRPV5. By combining whole-cell patch-clamp and Ca2+-
imaging techniques, we have characterized the electrophysiological properties of the 
TRPV5 channel and showed that treatment with 20 to 50 nM E2 rapidly (< 5 min)
induced a transient increase in inward whole-cell currents and intracellular Ca2+ via 
TRPV5 channels. This rise was significantly prevented when cells were pre-treated with 
ruthenium red and completely abolished in cells treated with siRNA specifically targeting 
TRPV5.
These data demonstrate for the first time, a novel rapid modulation of endogenously 
expressed TRPV5 channels by E2 in kidney cells. Furthermore, the results suggest 
calcitropic effects of E2. The results are discussed in relation to present concepts of non-
genomic actions of E2 in Ca
2+ homeostasis.
Key Words: estrogen; renal cortical collecting duct; epithelial calcium channel; TRPV5.
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1. Introduction
Calcium metabolism is of crucial importance to many vital physiological functions and 
the maintenance of the body Ca2+ homeostasis is essential to life. The modulation of 
intracellular Ca2+ activity by Ca2+ influx is one of the most universal signal transduction 
pathways in all cell types, from sensory signal transduction, cell growth, cardiovascular 
functions to gene expression [1]. Extracellular fluid calcium levels are handled and 
regulated by calcitropic hormones at three potential sites including, the gastrointestinal 
tract, kidney and bone. It is well established that Ca2+ is reabsorbed in kidney by a 
transcellular pathway. Ca2+ enters the epithelial cell passively across the apical membrane 
via Ca2+-selective channels down an electrochemical gradient, diffuses through the 
cytosol bound to intracellular proteins as calbindins and parvalbumin and actively 
extruded at the basolateral membrane through Ca2+ ATPase activity and Na/Ca exchange
[2].
Hormones, which are classically involved in Ca2+ homeostasis, include 1,25-
dihydroxyvitamin D3, parathyroid hormone and calcitonin [3; 4]. The idea that estrogen 
plays a role in Ca2+ homeostasis has been also established [5]. The involvement of 17-
estradiol (E2) in Ca
2+ homeostasis is clearly illustrated by the role of the hormone in bone 
mineralization and the finding that E2 deficiency in postmenopausal women results in 
bone loss arising from a negative Ca2+ balance [6; 7], which is associated with a rise in 
plasma and urinary Ca2+ [8]. However, studies have shown that the rise in urinary Ca2+ at 
menopause is not due to an increased filtered load, suggesting that E2 also has a role in
regulating renal Ca2+ handling [9]. Ca2+ supplementation can also reduce bone loss in 
these patients, suggesting an interaction between estrogen deficiency and Ca2+ balance 
[10]. However, the cellular mechanisms underlying E2 regulation of Ca
2+ reabsorption is 
still poorly understood in kidney.
A family of Ca2+-permeable cation channels has been discovered in the early 1990's; the 
Transient Receptor Potential (TRP) channels [11]. TRPV5 is a member of the TRPV 
subfamily [12] which is implicated in apical calcium entry in epithelia [13], shows a 
constitutive activity, and functions as a facilitative transporter. Although our knowledge 
of TRPV5 channel physiology is still relatively limited, TRP mutations have already been 
described that lead to kidney diseases [14].
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Because transcellular Ca2+ transport is fine-tuned to the body’s specific requirements, 
regulation of the transmembrane Ca2+ flux through TRPV5 is of particular importance for 
whole body Ca2+ homeostasis and is tightly controlled by hormones [15].
It has been demonstrated that TRPV5 protein expression is highly modulated by E2 in 
kidney [16]. In addition to genomic effects, it is well established that E2 can also exert 
rapid non-genomic effects on intracellular Ca2+ in various cell types: including 
hepatocytes, osteoblasts, enterocytes/monocytes and in distal colon [17-21]. Furthermore, 
there is increasing evidence for rapid, non-genomic, effects of E2 on epithelial ion 
transport [22-25]. In particular, in the kidney collecting duct M-1 cells, E2 has been 
shown to modulate intracellular Ca2+ levels through a calcium entry pathway [26]. On the 
basis of others and our previous studies, we hypothesize that E2 may have the ability to 
regulate renal Ca2+ re-absorption through rapid effects on TRPV5 channel activity.
Most electrophysiological studies to date on TRPV5 channels have been performed on 
over expressing channels in heterologous systems, CHO and HEK being the most 
commonly employed cell models. Our study is one of the few reports of hormonal 
modulation of endogenous TRPV5 channels.
1. Experimental
1.1 Cell Culture
RCCD2 cell line used in this study was previously characterized by Prof N. Farman’s 
group. Immortalized RCCD2 cells were obtained by infection of primary cultured CCD 
cells with the wild-type simian virus 40. It has been shown that this cell line has 
maintained many of the original properties of rat CCD from which they were derived 
[28]. RCCD2 cells were cultured in 75 cm
2 flasks or 35 mm glass-bottom dishes that had 
been coated with rat type I collagen, as previously described [27, 28]. Cells were cultured 
in a medium that contained 1:1 Ham’s F-12-DMEM with 14 mM NaHCO3, 20 mM 
HEPES buffer (pH 7.4), 10 U/ml penicillin-streptomycin, 2 mM glutamine, 5 g/ml 
insulin, 50 nM dexamethasone, 5 g/ml transferrin, 30 nM sodium selenite, 10 nM 
triiodothyronine, 10 ng/ml EGF, and 2% FBS (Gibco, Paisley, UK). RCCD2 cells were 
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maintained in serum-free medium and in the absence of dexamethasone and EGF 
overnight before treatment with oestrogen.
2.2 RT-PCR analysis
Total mRNA was isolated using TRI-REAGENT® (Molecular Research Center, USA)
according to the manufacture’s directions. Total RNA was reverse-transcribed into cDNA 
using ImProm-II™ Reverse Transcription System (Promega, USA). Primers for TRPV5 
(accession no. NM_019841) were designed using GeneFisher-software [29], and 
synthesized by MWG (Germany).
The primers used for amplification of TRPV5 were [Forward: ACCACTACAGGAAGC-
GTA; Reverse: CCGTCAATGATGGTAAGGA]. PCR amplification was performed with 
initial heating for 2 min at 94 °C, followed by 35 cycles of 1 min denaturation at 94 °C, 
annealing for 1 min at 51.5 °C and extension for 2 min at 72 °C. BLASTN search was 
performed on primers to confirm that the sequences were not shared with other known 
genes. The PCR products were resolved using a 1 % Tris-Borate-EDTA (TBE) agarose 
gel and the bands were analyzed via Gene Tools software (Syngene, UK). cDNA bands 
corresponding to TRPV5 transcripts were extracted from the agarose gel, purified using 
Quiaquick kit (Quiagen, UK) and  subsequently sequenced (MWG, Germany).
2.3 Western blot analysis
Western blotting experiments were carried out using standard technique with 
modifications [30]. Briefly, cells were gently washed twice with PBS and scraped into 
SDS sample buffer [62.5 mM Tris-HCl (pH 6.8 at 25 °C), 2 % w/v SDS, 10 % glycerol, 
protease inhibitors and 2 mM DTT]. Equal amounts of total protein were resolved on 8 % 
SDS-PAGE gels and transferred onto polyvinyl difluoride membranes using the semi-dry 
transfer technique. Membranes were blocked for 2 hr at room temperature in Tris 
Buffered Saline with Tween-20 (TBST) containing 5% non-fat dry milk and incubated 
for 1 hr at room temperature with rabbit-anti rat TRPV5 primary antibody diluted in 
blocking solution, (1/500 dilution), (ACC-035, Alomone labs). Membranes were washed 
3x10 min in TBST and incubated for 1 hr with HRP-Rabbit secondary antibody (1/5000 
dilution in TBST containing 5 % dried milk). After 3x10 min wash, immuno-reactive 
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proteins were detected using enhanced ECL plus chemiluminescent reagent (Amersham 
Biosciences, UK). 
Anti--actin monoclonal antibody (1/4000 dilution; Sigma, Ireland) was used as a loading 
control. Rat kidney cortex whole lysate and Chinese Hamster Ovary (CHO) cells were 
used as positive and negative controls, respectively.
2.4 Immunofluorescence microscopy
Four male Wistar rats were anesthetized by isoflurane inhalation and kidneys were 
perfusion fixed with 3% formaldehyde in phosphate buffer, pH 7.4 through the 
abdominal aorta. The tissues were dehydrated in graded ethanol, incubated overnight in 
xylene, and embedded in paraffin wax. 2 µm thick sections were cut using a rotary 
microtome (Leica, Heidelberg, Germany). The sections were dewaxed with xylene and 
rehydrated with graded ethanol. Endogenous peroxidase was blocked by 0.5% H2O2 in 
absolute methanol for 10 min. The sections were boiled in 10 mM tris with 0.5 mM 
EGTA, pH 9, for 10 min. After cooling, the sections were washed with 50 mM NH4Cl in 
PBS for 30 min followed by incubation with PBS blocking buffer containing 1% BSA, 
0.2% gelatin, and 0.05% saponin. The sections were incubated overnight at 4ºC with 
primary antibodies diluted in PBS supplemented with 0.1% BSA and 0.3% Triton X-100. 
Upon wash in PBS supplemented with 0.1% BSA, 0.2% gelatin, and 0.05% saponin dual 
or triple color fluorescence labeling were performed. The sections were incubated with 
fluorophore conjugated secondary antibodies (see below) in PBS supplemented with BSA 
and Triton-X-100. After washing, sections were mounted with a cover slip in Glycergel 
Antifade Medium (Dako), and inspected on a Leica DMRS confocal microscope using an 
HCX PlApo 64x (1.32 NA) objective. 
2.5 Antibodies
Primary antibodies were: mouse anti-calbindin D-28K (Research Diagnostics, Flanders, 
NJ) and rabbit anti-TRPV5 (ECAC1AP, alpha diagnostics). Fluorescent secondary 
antibodies were donkey anti-rabbit Alexa488 and donkey anti-mouse Alexa555 
(Invitrogen/Molecular Probes, Eugene, OR). Topro3 was used as a nuclear marker 
(Invitrogen).
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2.6 Electrophysiology
It was impossible to patch RCCD2 cells after 48 hr plating as the cells are flattened and 
whole-cell access configuration is difficult to achieve (Basolateral membrane not 
accessible to the bath solution changes). We therefore detached subconfluent cells from 6 
well plates using trypsin–EDTA. After centrifugation at 1100 rpm for 3 min cells were 
recovered in culture medium at room temperature.
Patch-clamp experiments were performed using the whole-cell patch-clamp configuration 
[31]. Isolated RCCD2 cells were transferred into a 1ml superfusion chamber mounted on 
the stage of an inverted microscope (Nikon) and perfused with modified Krebs "bath" 
solution. Patch pipettes were prepared from capillary glass (GC150 F-10, Harvard 
Apparatus Ltd, UK) using a puller (DMZ-Universal Puller, Zeitz-Instruments, Germany) 
and had a resistance of 3 to 5 M when filled with the pipette solution. The reference 
electrode was an Ag-AgCl wire in direct contact with the superfusion bath. The patch–
clamp apparatus consisted of a CV-203BU head stage (Axon Instruments Inc., CA, USA) 
connected to an Axopatch 200B series amplifier (Axon). Seal resistance was typically in 
the 1-5 G range. Recorded membrane whole-cell currents were amplified and digitized 
at 5 kHz and low pass-filtered at 1 kHz. Membrane voltage was clamped from –120 mV 
to +100 mV with steps of 20 mV. Average capacitance of the cell was approximately 
14.5 ± 2.2 pF. Drug actions were measured only after steady-state conditions were 
reached. 
2.7 Calcium-Imaging microscopy
Initially we used the same concentration of E2 (20 nM) in calcium imaging and patch-
clamp experiments, but E2 did not show any significant effect on intracellular calcium in 
calcium imaging. This could be due to the fact that at this concentration (20 nM) the 
accessibility of E2 is limited to the apical side of the cells. For Ca
2+ measurements cells 
were not trypsinised and were plated in glass cover slips and the basolateral membranes 
of the cells are stuck to the glass cover slip limiting drug and bathing solution access. 
However, in patch-clamp experiments, trypsinisation of cells allows the access of E2 to 
the whole-cell membrane. 
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RCCD2 cells were loaded for 45 minutes with 5 M FURA-2/AM. All experiments were 
performed in physiological solution (as above), at room temperature (20-22oC). Ca2+
“free” experiments performed in Krebs solution where calcium is omitted as previously 
described by Nilius et al. [12]. Cells were mounted on an inverted epi-fluorescence 
microscope (Diaphot 200, Nikon, Japan) and illuminated with a Xenon lamp (Cairn, UK) 
filtered through alternating 340 and 380 nm interference filters. The resultant 
fluorescence was passed through a 400 nm dichroic mirror, filtered at 510 nm and then 
collected using an intensified CCD camera system (Hammatsu, Japan). Images were 
recorded for 30 min, digitised and analysed using Openlab2 (Improvision, UK). Drug 
actions were measured only after steady-state conditions were reached.
2.8 Solutions and chemicals
For both calcium imaging and whole-cell patch-clamp experiments, cells were superfused 
with a “Krebs” solution containing (in mM): 145 NaCl; 6 CsCl; 1 MgCl2; 10 CaCl2 10 
HEPES and 10 glucose, pH 7.4 with CsOH. Na+-free conditions were obtained by using 
NMDG+ instead of Na+. When the extracellular CaCl2 concentration was increased, 
extracellular NaCl was equimolarly decreased respectively to keep the osmolarity 
constant. In divalent-free (DVF) solutions, Ca2+ and Mg2+ were omitted from the bathing 
solution. The patch pipette solution contained in all experiments (in mM): 20 CsCl; 100 
Cs-Aspartate; 1 MgCl2; 10 BAPTA (1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetra-
acetic acid);  Na2ATP 4, 10 HEPES  (pH 7.2). Chemicals were purchased from Sigma 
Chemical Co. (Ireland). In all experiments, stock solutions of E2 were prepared in 
methanol.  No effect of the methanol vehicle on TRPV5 currents was observed at the 
concentrations used to study E2 effects.
2.9 Synthesis and Transfection of siRNA for TRPV5
SiRNA sequences targeting rat TRPV5 were designed and synthesized using the Silencer 
Pre-designed siRNA construction kit (Ambion Research Inc., UK). The three specific 
TRPV5 target sequences used here are listed in table one. 
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RCCD2 cells were splited and re-suspended in an Opti-MEM
® I reduced Serum Medium 
(GIBCO, UK) for 12 hr prior to transfection. Sub-confluent cells (~ 50 % confluence) 
were transfected, between passages 10 to 25.
For each transfection, oligomer-LipofectamineTM 2000 complexes were prepared as 
follows: (i) siRNA oligomer 50 pmol was diluted in 100 l Opti-MEM® (Resulting 
concentration of siRNA is 100 nM) and the solution was gently mixed. (ii) Separately, 
LipofectamineTM 2000 (5 l) was diluted in 100 l of Opti-MEM®. The solution was 
gently mixed and incubated for 5 min at room temperature. (iii) The diluted oligomer and 
Lipofectamine 2000 were gently mixed and incubated for 30 min at room temperature. 
The siRNA and Lipofectamine 2000 complex was added to 1 ml Opti-MEM® per well. 
Six-well plates were incubated at 37oC for 6 hr. thereafter; the medium was changed to a 
full culture medium for 48 hr.
For functional studies and to monitor transfection efficiencies cells were transfected with 
a FAM tagged siRNA. Functional non-coding siRNA#1 (Ambion Research Inc.) was 
used as a control.
2.10 Data analysis
The densitometry of the TRPV5 bands were normalized to the loading control, -actin. 
Densitometric analysis of the western blots were performed using GeneTools software
(SYNGENE, Cambridge UK). All data are reported as mean ± S.E.M for a series of the 
indicated number of experiments. Patch-clamp data analysis was performed using the 
clampfit software of the p-clamp suite version 9.2 and Origin 7.5 (OriginLab Corp, MA, 
USA). Statistical analysis of the data was obtained using a paired t-test for analysis 
between two groups, a p value < 0.05 was considered significant. One-way ANOVA was 
used for multiple analyses of more than two groups.
3. Results
3.1 Expression and electophysiological properties of TRPV5 in RCCD2 Cells
We explored the presence of TRPV5 channels in RCCD2 cells by RT-PCR. Figure 1A 
shows a single band of about 550 bp corresponding to TRPV5 transcript in RCCD2 cells. 
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Subsequent sequencing of the band confirmed that it corresponded to the cDNA sequence 
of TRPV5. To further confirm the expression of TRPV5 in RCCD2 cells, Western blot 
analysis was performed and revealed a band with a molecular size of ~ 90 kDa, 
corresponding to TRPV5 protein (Figure 1B). Rat kidney cortex was included as a 
positive control for both RT-PCR and Western blot. CHO cells were included as negative 
control for Western immunoblotting. To evidence the presence of TRPV5 in cortical 
collecting ducts, immunolocalization experiments were performed. Immunofluorescence 
microscopy revealed that luminal anti-TRPV5 immunoreactivity extends from the 
calbindin-positive late distal convoluted tubules (DCT2) and connecting tubules (CNT) 
into a subset of cells of the initial cortical collecting ducts (iCCD, Figure 1C). These 
patterns were observed in all four rats tested. Thus, luminal anti-TRPV5 labelling was 
restricted to DCT2, CNT and iCCD. Anti-TRPV5 staining was not detected in any other 
renal structures.
Based on these results, we investigated the electrophysiological properties of TRPV5 in 
these cells. Figure 2A compares the whole-cell current bathed with either external 
solution containing 1, 10 and 100 mM Ca2+ or in divalent free (DVF) solution with Na+
as the major charge carrier of the currents. Under DVF solution, cells generated large 
inward currents that are completely abolished by replacing extracellular NaCl with 
NMDG-Cl. Re-application of NaCl to the bathing solution re-established the inward 
currents. Figure 2B show the current-voltage (I-V) relationship in the presence of 
increasing [Ca2+]e (in mM: 1.5, 10, 20 and 100). Extracellular Ca
2+ induces inward 
current with amplitude that depends on the [Ca2+]e indicating that it is carried by Ca
2+. 
We examined the effects of various membrane holding potentials on whole-cell currents 
in RCCD2 cells. Figure 3A shows typical whole-cell current traces recorded at -120 mV 
at different holding potentials of +20, -50, -80 and -110 mV as indicated in the graph. 
Whole-cell current measurements showed that current amplitudes increased in a voltage-
dependent manner upon hyperpolarization (Figure 3B). At a holding potential of -110 
mV, the current measured at -120 mV was larger than the currents recorded at the same 
voltage when initiated from more depolarised holding potentials (-1242 ± 117 pA at -110 
mV; -997 ± 121 pA at -80 mV;  -312 ± 89 pA, at -50 mV; -88 ± 71 pA at +20 mV, n = 7). 
In addition, I-V profiles characterized by inward rectification at negative membrane 
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potentials recorded in these cells resemble those of TRPV5 previously reported by 
Clapham et al.  [32]. These results support the hypothesis that calcium influx may occur 
via TRPV5 in RCCD2 cells.
A dose-response study of the rapid effects of E2 on whole-cell Ca
2+ currents was 
performed in RCCD2 cells (Figure 4). Treatment with increasing concentration of E2 (in 
nM; 1, 10, 20, and 50) stimulated inward whole-cell Ca2+ currents in a dose-dependent 
manner.  Cells generated inward currents that amplitudes increases from -225 ± 87 pA at 
1nM E2 to  -306 ± 108 pA at 10 nM E2, - 844 ± 122 pA, at 20 nM E2 and to - 788 ± 113 
pA at 50 nM E2, n = 9). The maximum peak current amplitude obtained was at 20 nM E2 
therefore, we used this concentration for subsequent studies in all patch clamp 
experiments.
3.2 Intracellular Ca2+ rise induced by E2 is sensitive to ruthenium red in RCCD2
cells
3.2.1 Calcium imaging
The effect of 20 nM E2 on [Ca
2+
]i was examined in RCCD2 cells. As shown in Figure 5A, 
E2 treatment modulates cytosolic Ca
2+ levels.  In 35 % (n = 108) of the cells examined, E2
induced a rapid transient peak rise in [Ca
2+
]i. Vehicle controls (physiological solution 
alone or with 5x10
-5
% methanol) had no effect on [Ca
2+
]i (Figure 5A).
To test if the E2-induced increase in [Ca
2+]i originated from an extracellular source, we 
monitored the effect of E2 in RCCD2 cells bathed with “low” (1.5 mM)  extracellular  
Ca2+) solution. Under these conditions, E2 treatment did not alter [Ca
2+
]i, and subsequent 
thapsigargin treatment triggered a rise in intracellular Ca2+ indicating that the release of 
calcium ions from internal stores was still possible but was not activated by E2. These 
data indicate that the rise in (Ca2+)i induced by E2 is initiated by an influx of Ca
2+ into the 
cell from the extracellular space and not by an initial release from intracellular stores. 
To investigate the contribution of TRPV5 in the E2-induced Ca
2+ rise cells were pre-
treated with ruthenium red, a well-known effective blocker of highly-Ca2+ selective 
channels [33]. Figure 5B shows that E2 induced a rise in Ca
2+ of 18.3 ± 1.6 % above basal 
(n = 38 cells) this rise was significantly reduced to 9.7 ± 0.6 % above basal (n = 25 cells, 
p <  0.002) when cells were pre-treated with ruthenium red (50 M).
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Interestingly, the number of cells responding to E2 with a rise in Ca
2+ was also 
significantly decreased when cells were pre-treated with ruthenium red (19% in 
ruthenium red + E2 vesus 35% of cells responding in E2 alone, n = 131).
Taken together, these data further strengthen the conclusion that E2 stimulates calcium 
influx via TRPV5 in RCCD2 cells.
3.2.2 Patch-clamp
RCCD2 cells were stimulated with E2 in the presence or absence of ruthenium red. Figure 
6 illustrates representative whole-cell current traces in (a) control (untreated) and in E2
(20 nM) treated cells in the absence (b) or presence (c) of ruthenium red (50 M). 
Addition of ruthenium red to the bath induces substantial decrease in current amplitudes. 
Figure 6 d shows I-V relationship measurements demonstrating that E2 application 
stimulated a mean maximal increase in inward whole-cell currents. E2 increased whole-
cell current amplitudes from basal values in control (untreated) cells of -222 ± 47 pA to -
734 ± 68 pA at a Vp = -120 mV (n = 10, p < 0.01).  Adding ruthenium red significantly 
reduces the E2-activated mean maximal increase in whole-cell currents from -734 ± 68 
pA to -255 ± 57 pA at a Vp = -120 mV (n = 7, p < 0.02), corresponding to a reduction in 
current of approximately 65%. 
The whole-cell conductance (Gc) calculated over the Vp range –120 to –60 mV was 
increased to 403 ± 23 pS (n = 10, p < 0.01) with E2 treatment compared to control 
untreated cells (111 ± 5 pS). Exposure of cells to ruthenium red (50 M) reduced the E2 -
induced Gc to 119 ± 12 pS (n = 7, p < 0.02), which was not significantly different from 
the Gc recorded in control (untreated) cells, (111 ± 5 pS, n = 7, p>0.05). These data 
reinforce the conclusion of the contribution of TRPV5 channels in response to E2 induced 
whole-cell inward Ca2+ currents in RCCD2 cells. 
3.3 E2-induced calcium entry channels activation is suppressed by siRNA 
targeting TRPV5 in RCCD2 cells
As ruthenium red has been only reported as an effective but not specific inhibitor of 
TRPV5 channel [33], siRNA has been employed to specifically suppress TRPV5 
expression and activity. Three different siRNAs (siRNA#1, siRNA#2 and siRNA#3) 
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targeting different sequences of TRPV5 were tested in RCCD2 cells (Table 1). Figures 
7A and B illustrate the expression of TRPV5 protein in control siRNA (Functional non-
coding siRNA #1, Ambion Research Inc., UK) and three TRPV5-siRNAs transfected 
RCCD2 cells. Western blot analysis revealed no significant decrease in TRPV5 
expression following transfection of individual siRNA (Figure 7A, B; Lane 2-4). 
However, combination of co-transfections is more efficient. The most efficient silencing 
expression of TRPV5 was the co-transfection with siRNA#2 and #3 (Lane 7). Therefore, 
co-transfection of RCCD2 cells with siRNA#2 and#3 has been used for functional studies 
and the control functional non-coding siRNA#1 has been used as control-siRNA. The 
possibility that the calcium influx is mediated by TRPV6 has been tested and no
significant knockdown expression of TRPV6 was obtained when cells were transfected or 
co-transfected with different siRNA targeting TRPV5 (Figure 7A). Western blot in 
Figure 7A TPRV6 expression seems to be downregulated by some siRNAs, particularly 
siRNA 2 and 3. This is a representative Western blot, on average of three different 
experiments, no statistically significant difference has been found. 
Figure 8 shows (A) a typical I-V relationship experiment and (B) averaged data of whole-
cell Ca2+ currents entering through TRPV5 obtained at the first voltage step of -120 mV. 
The results showed that E2 induced inward whole-cell currents rise in cells transfected 
with control functional non-coding siRNA, but E2 failed in cells co-transfected with 
siRNA#2/3, corresponding to E2 control of -1089 ± 92 pA (at Vp = -120 mV), (n = 12, p 
<0.005) compared to E2 responses in siRNA#2/3 cells of -141 ± 44 pA (at Vp = -120 
mV), (n = 6, p <0.005). Taken together, these results demonstrate that co-transfection 
with siRNA#2/3 substantially decreased TRPV5 protein expression level leading to the 
inhibition of TRPV5 activity and E2 activation of [Ca
2+]i rise involving TRPV5 channels.
4. Discussion
This study provides, for the first time, evidence of a rapid stimulatory effect of 17-
estradiol on [Ca2+]i involving TRPV5.
Using RT-PCR and Western blot analysis we have demonstrated that TRPV5 is present at 
both mRNA and protein expression levels in RCCD2 cells. We have also provided 
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evidence for expression of TRPV5 in native iCCD in addition to the DCT2 and CNT 
localization. Using the patch-clamp technique, we studied the electrophysiological 
properties of Ca2+-dependent channels in RCCD2 cells. In the presence of monovalent 
cations and Ca2+ these channels initially display decrease of currents as extracellular Ca2+
levels are reduced, but at very low extracellular Ca2+ levels, currents then increase 
beyond the amplitude observed in the presence of high extracellular Ca2+ levels, due to 
the increasing permeability to monovalent cations including Na+, loss of selectivity in the 
absence of divalent cations. This behaviour is thought to be related to the affinity 
difference between monovalent and divalent cations in the channel pore. These Na+/Ca+
selectivity features are in agreement with those reported previously by Nilius B et al.,
2001. Whole-cell current was minimal over a ± 100mV range under 1.5 mM Ca2+
conditions and was significantly activated by increasing [Ca2+]e. The Ca
2+-dependent 
whole-cell current could also be activated at any given extracellular calcium 
concentration by membrane hyperpolarization. The [Ca2+]e and voltage dependence 
characteristics are known features of TRPV5 channels and, taken together with the RT-
PCR and Western blotting data, indicate the functional expression of TRPV5 channels in 
RCCD2 cells.
The E2-induced whole-cell and [Ca
2+]i were increased when cells were exposed to 
increasing [Ca2+] in the bath solution, indicating that Ca2+ influx is initiated from the 
extracellular compartment and involves Ca2+ entry into the cell. Patch-clamp
measurements performed under similar conditions demonstrated that the whole-cell 
conductance has been substantially decreased and remained unaffected by E2 treatment 
when Ca2+ was removed from the extracellular bathing solution.  Ruthenium red is
known to be the most effective blocker of TRPV5 (IC50= 111nM), [33].
In RCCD2 cells, the maximum inhibitory effect of ruthenium red (RR) was obtained only 
at 50 M, 1-10 M RR have been tested and no significantly inhibitory effect on the E2
induced currents was observed (data not shown). Pre-treatment of cells with 50 M 
ruthenium red in the bathing solution significantly reduced the number of cells 
responding with a rise in [Ca2+]i after E2 exposure. Moreover, patch-clamp analysis 
showed a decrease in whole-cell conductance by 70% when the cells were pre-treated 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
- 15 -
with ruthenium red before E2 stimulation. These results implicate Ca
2+ entry via possibly 
TRPV5 during E2 response. 
SiRNA knockdown was employed as an alternative approach to specifically suppress 
TRPV5 channel expression and activity. To assess the importance of TRPV5 expression 
in RCCD2 cells, and its contribution to E2 induced rise in [Ca
2+]i, specific siRNA was 
transfected into RCCD2 cells. Since different siRNAs targeting the same gene are often 
differentially effective in silencing the expression of their target, three different siRNAs 
(siRNA#1, siRNA#2 and siRNA#3) directed against different target sequences in rat 
TRPV5 were transfected into RCCD2 cells (Table 1). Combined co-transfection with 
siRNA#2 and siRNA#3 showed substantial silencing of TRPV5 protein expression level 
in RCCD2 cells. To associate the expression silencing to functional silencing, whole-cell 
current measurements were performed in TRPV5 siRNA transfected cells compared to 
control functional non-coding siRNA treated cells. The siRNA knockdown experiments 
clearly provide the evidence of the contribution of TRPV5 in E2-induced Ca
2+ influx in 
RCCD2 cells.
As the latency of onset of steroid hormone genomic responses is approximately 30 min, 
our results represent a rapid (within 3 to 6 minutes) non-genomic response to E2. The 
physiological role for non-genomic action of 17estradiol in renal cortical duct cells 
may serve to enhance the retention and re-absorption of Ca2+. Taken together, the results 
of our studies indicate that 17-estradiol induces a rapid intracellular calcium response 
via Ca2+ entry through the epithelial Ca2+ channels TRPV5 in RCCD2 cells. The signaling 
mechanisms and receptor(s) involved in E2 modulation of TRPV5 channels and their role 
in transepithelial Ca2+ transport remain to be identified.
To date TRPV5 has not been localized to CCD while TRPV6 has. Thus we showed that
TRPV6 is expressed in these cells. Further, the close homology between these channels 
may falsely identify one as the other despite several approaches. Functionally, it will be 
hard to discriminate between both channels. To this end proof that the siRNA and 
antibody is specific for TRPV5 and not TRPV6 has been preformed. To discriminate 
between TRPV5 and TRPV6, Western blot experiments demonstrated that si-RNA-
TRPV5 knock-down does not affect the expression of TRPV6 (see Fig. 7A). In addition, 
based on knock-down functional experiments (i.e. in both patch-clamp or Ca2+ imaging 
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experiments we haven’t seen any significant [Ca2+]i increase after E2 stimulation in 
TRPV5-siRNA transfected cells), we concluded that TRPV5 play a key role in this Ca2+
response and we considered that TRPV5 was the major Ca2+ channel involved in 
response to E2 stimulation in RCCD2 cells.
Functional regulatory mechanism of TRPV channels by estrogen in renal collecting duct 
cells is of great importance for the better understanding of transepithelial reabsorption of 
calcium and, as a consequence, may reveal novel pharmacological and therapeutic targets 
for the treatment of several disorders of calcium metabolism such as idiopathic 
hypercalciuria, stone disease and postmenopausal osteoporosis.
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Figure legends
Figure 1 Expression of TRPV5 in RCCD2 cells. A) Agarose gel electrophoresis of mRNA 
products obtained by the RT-PCR method for amplifying base pair sequences for TRPV5. 
PCR product sizes were determined by comparing to DNA ladder (lane 1). The ~550 bp 
band represents TRPV5 (lane 2). No bands were obtained in negative controls with no 
mRNA template or reverse transcriptase (lane 3 and 4). Expression of TRPV5 mRNA in 
native tissue kidney cortex (lower panel) was included as a positive control. B) Western 
blot analysis of extracts from RCCD2 cell lysates (Lane 2), rat kidney cortex (lane 1, 
positive control) and CHO cell lysates (lane 3, negative control). Blots were probed with 
Anti-TRPV5 antibody (Upper blot). Bands of ~ 90 kDa corresponding to the expected 
size of TRPV5 protein were detected in RCCD2 cells and rat kidney cortex tissue but not 
in CHO cells. As a loading control, blots were stripped and reprobed with an anti--actin 
antibody (Lower blot). Bands corresponding to TRPV5 and -actin are indicated by 
arrows and the corresponding molecular weight (kDa), respectively. The data are 
representative of 3 experiments. C) Immunohistochemical analysis of TRPV5 and 
calbindin D-28K in rat isolated CCD sections. Rat Kidney sections were incubated for 
overnight at 4 ºC with the corresponding primary antibodies mouse anti-calbindin-D28K 
(dilution: 1:40 000) and guinea rabit anti-TRPV5 (dilution 1:100). To visualize the 
proteins corresponding secondary Alexa 488/555 (dilution 1:1000) conjugated antibodies 
were used. Tropro3 (dilution 1: 1000) was used as a nuclear marker.
Figure 2 Whole-cell currents are [Ca2+]e dependent in RCCD2 cells. Whole-cell 
recordings were elicited from +20 mV holding potential in 20 mV steps from -120 mV to 
+100 mV. The patch pipette was filled with a standard cesium-aspartate solution 
supplemented with 10 mM of BAPTA. Cells were first perfused with DVF solution then 
with increasing of extracellular Ca2+ concentrations. A) Whole-cell currents were 
recorded in DVF conditions. The presence of Na+ as the major charge carrier in the 
external solution resulted in large inward current amplitudes which were completely 
abolished when Na+ was replaced by NMDG+. Addition of 1, 10 and 100 mM of Ca2+ in 
monovalent free external solution induced an  inward transient current that amplitude 
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depends on the [Ca2+]e. B) Current/voltage relationships recorded by measuring the 
amplitude of currents at: 1.5 mM Ca2+ (), 10 mM Ca2+ (), 20 mM Ca2+ () and 100 
mM Ca2+ (). Data are mean ± SEM, n = 7 cells obtained from 7 separate experiments.
Figure 3 Whole-cell currents are voltage-dependent in RCCD2 cells. Cells were 
incubated in Krebs solution containing 10 mM Ca2+ in the perfusion medium and 10 mM 
BAPTA in the pipette solution. From a holding potential of +20 mV the membrane 
potential was changed to -50 mV, -80 mV and -110 mV. Currents were measured at the 
first voltage step of -120 mV. (A) Original typical whole-cell currents traces recorded at 
different holding potentials as indicated in the graph. (B) Averaged data representing 
currents recorded from 7 cells at different holding potentials at the first step of –120 mV. 
Data represent the mean ± S.E.M of 7 cells.
Figure 4 Effect of E2 on whole-cell currents in RCCD2 cells. Whole-cell recordings were 
elicited from +20 mV holding potential in 20 mV steps from -120 mV to +100 mV in 
RCCD2 cells. Cells were allowed to stabilize and dialyze for at about 5 minutes before 
exposure to E2. Treatment of cells with increasing concentrations of E2 (in nM: 1, 10, 20, 
50) induced a dose-dependent current amplitudes increases.  The maximum peak increase 
was obtained at 20 nM E2. The results shown are tracings of representative cells with
similar results observed in separate experiments from 9 cells. Arrow indicates time of 
addition of E2.
Figure 5 17-estradiol induces increase in [Ca2+]i in RCCD2 cells. A) Addition of E2 (50 
nM) induced a rapid increase in [Ca2+]i (). E2-induced [Ca2+]i increase were typically 
rapid in onset and transient and returned to basal levels within 1-2 min. No increase in 
[Ca2+]i levels were observed in response to vehicle (5.10
-5 % methanol), (●), or 
physiological solution alone (▲). The X-axis represents time after the drug addition (the 
arrow represents time of E2 addition). All measurements have been normalized with the 
base line emission wavelength ratio being fixed at 1. As a positive control to store filling, 
thapsigargin (1 µM) was added to the bathing solution at the end of each experiment. B)
E2-induced Ca
2+ entry is sensitive to ruthenium red. 50 nM E2 induced a significant 
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increase over control [Ca2+]i (normalized increase above basal = 118 ± 2 ; n = 38 vs 
control 100, nt = 38). Pre-incubation with the potent TRPV5 blocker, ruthenium red (50 
M), significantly inhibited the E2-induced increases in [Ca2+]i to 110 ± 1 (n = 25). 
Values are presented as means ± S.E.M. (*denotes significant differences:  *** p <
0.001).
Figure 6 E2-induced inward Ca
2+ currents are sensitive to ruthenium red. Cells were 
stimulated with 20nM E2, either in the presence or absence 50 M of ruthenium red 
(RuR), or “low” (1.5 mM) extracellular Ca2+ conditions. The pipette solution was 
supplemented with 10 mM BAPTA. (a) Typical whole-cell current traces recorded in 
control (untreated) cells. (b) Typical whole-cell current traces recorded in E2 treated cells 
(20 nM E2). (c) Typical whole-cell current traces recorded showed that the increase of 
Ca2+ currents induced by E2 treatment was prevented when cells were pretreated for 15 
min with 50 M RuR. (d) Current / voltage relationships of TRPV5 channels:  20 nM E2
in “low” Ca2+ conditions (); Krebs supplemented with 10 mM Ca2+, 20 nM E2 + 50 M 
RuR (); 20 nM E2 alone (). Data represent the mean ± S.E.M of 7 cells (p < 0.02).
Figure 7 SiRNA knockdown of rat TRPV5 protein expression in RCCD2 cells. A) Western 
blot experiments performed with total protein prepared from RCCD2 epithelial cells.
Lane 1: non-coding siRNA transfected cells (control); lane 2, 3 and 4: Transfected cells 
with siRNA#1; #2 and #3, respectively. Lane 5, 6, 7 and 8: Combined co-transfected 
cells with siRNA#1 & #2; siRNA#1 & #3; siRNA#2 & #3; and siRNA#1, #2 & #3, 
respectively. B) Immuno-blot analysis showed that cells co-transfected with siRNA#2 #3
are the most efficient for silencing TRPV5 protein expression relative to their controls.
Functional non-coding control #1 (Ambion, LTD, UK) has been used as siRNA control. 
TRPV6 has been used as a control to examine the specificity of TRPV5 knockdown 
expression. Note that no significant knockdown expression of TRPV6 in all RCCD2 cells 
transfected with different siRNAs targeting TRPV5. -actin has been used as loading 
control. Data are representative of three similar experiments.
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Figure 8 Rapid effect of E2 on Ca
2+ currents in siRNA-TRPV5 transfected cells. Patch 
clamp experiments were performed in cells either transfected with control siRNA or co-
transfected with siRNA#2/3. Cells were treated with E2 (20 nM) in the presence of 10 
mM Ca2+ in the bath solution. A) Representative Current/voltage relationship experiment 
performed in cells transfected with functional non-coding siRNA (n = 8) and cells co-
transfected with siRNA#2/3 (n = 8), B) Normalized data of E2 induced TRPV5 currents 
recorded at the first voltage step of -120 mV from cells transfected with control siRNA 
and siRNA#2/#3. Data represent the mean ± S.E.M. (*** Indicates significant differences 
between control and transfected cells, p < 0.02).
Table 1: Target sequences of rat TRPV5 siRNA
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